Back
CG Oncology, Inc. 10K Form
Sell
37
CGON
CG Oncology, Inc.
Last Price:
$43.29
Seasonality Move:
-29.45%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CGON News And Ratings
See the #1 stock for the next 7 days that we like better than CGON
CGON Financial Statistics
Sales & Book Value
| Annual Sales: | $1.1M |
|---|---|
| Cash Flow: | $-39M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $8.78 |
| Price / Book: | 4.8 |
Profitability
| EPS (TTM): | -1.98410 |
|---|---|
| Net Income (TTM): | $-151.5M |
| Gross Margin: | $1.1M |
| Return on Equity: | -22.73% |
| Return on Assets: | -21.85% |
CG Oncology, Inc. Earnings Forecast
Key CG Oncology, Inc. Financial Ratios
-
The Gross Profit Margin over the past 4 years for CGON is 97.19%.
-
The Selling, General & Administrative Expenses for CGON have been equal to 2,959.00% of Gross Profit Margin.
-
The Research & Development expenses have been 7,208.25% of Revenue.
-
The Net Earning history of CGON is -7,729.50% of Total Revenues.
-
Per Share Earnings over the last 4 years have been positive in 0 years.
CG Oncology, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | CGON |
| Website: | cgoncology.com |
Debt
| Debt-to-Equity Ratio: | 0.01 |
|---|---|
| Current Ratio: | 22.79 |
| Quick Ratio: | 22.3 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
CGON Technical Analysis vs Fundamental Analysis
Sell
37
CG Oncology, Inc. (CGON)
is a Sell
Is CG Oncology, Inc. a Buy or a Sell?
-
CG Oncology, Inc. stock is rated a SellThe current CG Oncology, Inc. [CGON] share price is $43.30. The Score for CGON is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.